Associated Papers
Engineering of a novel subnanomolar affinity fibronectin III domain binder targeting human programmed death-ligand 1.
Ramakrishnan S et al.
Protein Engineering, Design & Selection : Peds, 2019
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy.
Bruera G et al.
Oncotarget, 2018
Select a paper to view details